tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Outlook for Cartesian Therapeutics: Buy Rating Backed by Advancements in Descartes-08 Trials and Strong Financial Projections
PremiumRatingsPromising Outlook for Cartesian Therapeutics: Buy Rating Backed by Advancements in Descartes-08 Trials and Strong Financial Projections
2M ago
Cartesian announces first participant enrolled in Phase 3 AURORA trial
Premium
The Fly
Cartesian announces first participant enrolled in Phase 3 AURORA trial
2M ago
Cartesian selloff brings ‘attractive buying opportunity,’ says Mizuho
Premium
The Fly
Cartesian selloff brings ‘attractive buying opportunity,’ says Mizuho
3M ago
Promising Growth Potential for Cartesian Therapeutics: Buy Rating Affirmed by Analyst Gil Blum
PremiumRatingsPromising Growth Potential for Cartesian Therapeutics: Buy Rating Affirmed by Analyst Gil Blum
4M ago
Promising Potential of Cartesian Therapeutics’ Descartes-08 in gMG Treatment: A Buy Recommendation
Premium
Ratings
Promising Potential of Cartesian Therapeutics’ Descartes-08 in gMG Treatment: A Buy Recommendation
4M ago
Promising Clinical Data and Future Prospects Drive Buy Rating for Cartesian Therapeutics
Premium
Ratings
Promising Clinical Data and Future Prospects Drive Buy Rating for Cartesian Therapeutics
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100